One-year visual and anatomical outcomes of intravitreal faricimab injection for neovascular age-related macular degeneration after prior brolucizumab treatment

One-year visual and anatomical outcomes of intravitreal faricimab injection for neovascular age-related macular degeneration after prior brolucizumab treatment

Abstract This single-center retrospective cohort study analyzed the 1-year real-world treatment outcomes of 63 consecutive eyes (of 60 patients) with neovascular age-related macular degeneration (nAMD) that were switched from intravitreal brolucizumab (IVBr) to intravitreal faricimab (IVF) and manag...

Full description

Bibliographic Details
Main Authors: Hironori Takahashi, Satoru Inoda, Hidenori Takahashi, Ryota Takahashi, Yuto Hashimoto, Hana Yoshida, Hidetoshi Kawashima, Yasuo Yanagi
Format: Article
Language:English
Published: Nature Portfolio 2024-04-01
Series:Scientific Reports
Subjects:
Brolucizumab
Age-related macular degeneration
Faricimab
Switching
Online Access:https://doi.org/10.1038/s41598-024-59894-8

Internet

https://doi.org/10.1038/s41598-024-59894-8

Similar Items